Uaci Seeds & Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.15 Cr
as on 12-12-2024
- Paid Up Capital ₹ 6.13 Cr
as on 12-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.00 Cr
as on 12-12-2024
- Revenue 10643.13%
(FY 2022)
- Profit 528.68%
(FY 2022)
- Ebitda 1206.58%
(FY 2022)
- Net Worth 25.12%
(FY 2022)
- Total Assets 14.62%
(FY 2022)
About Uaci Seeds & Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.15 Cr and a paid-up capital of Rs 6.13 Cr.
The company currently has active open charges totaling ₹22.00 Cr.
Subhomoy Roy and Sushmita Roy serve as directors at the Company.
- CIN/LLPIN
U36999WB2020PTC237136
- Company No.
237136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Uaci Seeds & Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhomoy Roy  | Director | 01-May-2020 | Current |
| Sushmita Roy | Director | 01-May-2020 | Current |
Financial Performance of Uaci Seeds & Biotech.
Uaci Seeds & Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10643.13% increase. The company also saw a substantial improvement in profitability, with a 528.68% increase in profit. The company's net worth Soared by an impressive increase of 25.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uaci Seeds & Biotech?
In 2023, Uaci Seeds & Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uaci Cropscience Private LimitedActive 8 years 11 monthsSubhomoy Roy and Sushmita Roy are mutual person
- Aureum Agrigenetics Private LimitedActive 1 year 8 months
Subhomoy Roy and Sushmita Roy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 May 2024 | ₹5.00 M | Open |
Others Creation Date: 04 Dec 2023 | ₹1.05 Cr | Open |
Hdfc Bank Limited Creation Date: 17 Mar 2022 | ₹1.44 M | Open |
How Many Employees Work at Uaci Seeds & Biotech?
Uaci Seeds & Biotech has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uaci Seeds & Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uaci Seeds & Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
